Published in Circ Res on March 19, 1999
Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein. Hypertens Res (2011) 1.50
Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol (2013) 1.08
Maturation and the role of PKC-mediated contractility in ovine cerebral arteries. Am J Physiol Heart Circ Physiol (2009) 1.01
Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J Mol Cell Cardiol (2014) 0.92
Novel signaling mechanisms of intracellular angiotensin II-induced NHE3 expression and activation in mouse proximal tubule cells. Am J Physiol Renal Physiol (2012) 0.91
c-Jun NH₂-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle. Yonsei Med J (2011) 0.87
17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation. Br J Pharmacol (2013) 0.86
Maturation and long-term hypoxia-induced acclimatization responses in PKC-mediated signaling pathways in ovine cerebral arterial contractility. Am J Physiol Regul Integr Comp Physiol (2010) 0.86
Downregulation of Angiotensin II-Induced 12-Lipoxygenase Expression and Cell Proliferation in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats by CCL5. Korean J Physiol Pharmacol (2009) 0.82
Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK. Br J Pharmacol (2008) 0.82
All-trans retinoic acid promotes smooth muscle cell differentiation of rabbit bone marrow-derived mesenchymal stem cells. J Zhejiang Univ Sci B (2010) 0.80
AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice. Am J Physiol Renal Physiol (2012) 0.80
Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.79
Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2. Exp Biol Med (Maywood) (2015) 0.76
The extracellular signal-regulated kinase (ERK) pathway: a potential therapeutic target in hypertension. J Exp Pharmacol (2012) 0.75
Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes. Int J Hypertens (2013) 0.75
Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide. Indian J Pharmacol (2009) 0.75
Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ (1993) 6.20
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev (2000) 3.40
Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension (2001) 3.04
Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol (2004) 2.46
c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 2.16
The first SSR-based genetic linkage map for cultivated groundnut (Arachis hypogaea L.). Theor Appl Genet (2008) 2.04
Vascular remodeling. Hypertension (1996) 1.99
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res (1998) 1.97
Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension (2000) 1.63
Fracture mechanisms in bulk metallic glassy materials. Phys Rev Lett (2003) 1.52
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension (2001) 1.50
Pigeonpea genomics initiative (PGI): an international effort to improve crop productivity of pigeonpea (Cajanus cajan L.). Mol Breed (2009) 1.46
Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats. J Hypertens (1996) 1.41
Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens (1995) 1.39
Disgust and the insula: fMRI responses to pictures of mutilation and contamination. Neuroreport (2004) 1.36
Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. Am J Physiol Cell Physiol (2001) 1.34
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry (2013) 1.31
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation (1999) 1.31
Nucleotide excision repair of DNA by human cell extracts is suppressed in reconstituted nucleosomes. J Biol Chem (1991) 1.29
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension (1999) 1.28
Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol (2008) 1.28
p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol (2004) 1.26
A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ (2010) 1.23
Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol (1999) 1.20
Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens (2001) 1.20
Connectivity brain networks based on wavelet correlation analysis in Parkinson fMRI data. Neurosci Lett (2011) 1.17
Household CO and PM measured as part of a review of China's National Improved Stove Program. Indoor Air (2007) 1.17
Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension (1999) 1.17
Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension (1999) 1.13
Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension (1993) 1.13
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene (2006) 1.13
Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med (1985) 1.12
Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens (2001) 1.11
Overexpression of Hp95 induces G1 phase arrest in confluent HeLa cells. Differentiation (2001) 1.10
Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med (1998) 1.08
Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. Neuroimage (2011) 1.07
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Hypertension (1994) 1.07
Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage (2011) 1.07
Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension (2000) 1.06
Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens (2001) 1.04
Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2007) 1.04
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens (1999) 1.04
Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet (1995) 1.03
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism. Circulation (2001) 1.02
Development and use of EST-SSR markers for assessing genetic diversity in the brown planthopper (Nilaparvata lugens Stål). Bull Entomol Res (2011) 1.00
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J (2009) 1.00
Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection. Transplantation (1991) 1.00
Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens (2001) 1.00
Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats. Hypertension (2001) 1.00
Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (1993) 0.99
Identification of a biologically active circulating form of rat atrial natriuretic factor. Biochem Biophys Res Commun (1985) 0.99
A study of rare structural variants in schizophrenia patients and normal controls from Chinese Han population. Mol Psychiatry (2008) 0.98
Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. Hypertension (1993) 0.97
Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry (2004) 0.97
Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol (2000) 0.97
Prevalence of Eimeria species in broilers with subclinical signs from fifty farms. Avian Dis (2009) 0.97
Cytotoxic prenylated depsidones from Garcinia parvifolia. J Nat Prod (2000) 0.96
Disappearance of atrial natriuretic factor from circulation in the rat. Peptides (1986) 0.96
Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circulation (1999) 0.95
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens (2007) 0.94
Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci (Lond) (1995) 0.94
Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Am J Hypertens (2001) 0.94
Cyclic GMP as mediator and biological marker of atrial natriuretic factor. J Hypertens Suppl (1986) 0.94
CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation (2001) 0.93
Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension (2001) 0.93
Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection. J Immunol (2001) 0.92
p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension (2001) 0.92
Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. Mol Carcinog (1992) 0.91
Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res (2005) 0.91
Mechanism of captopril-induced drinking. Am J Physiol (1982) 0.91
Vascular and adrenal receptors for atrial natriuretic factor in the rat. Circ Res (1985) 0.91
A tunable reentrant resonator with transverse orientation of electric field for in vivo EPR spectroscopy. J Magn Reson (1999) 0.90
Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol (1992) 0.90
Pyrosequencing the midgut transcriptome of the brown planthopper, Nilaparvata lugens. Insect Mol Biol (2011) 0.89
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension (1995) 0.89
Antioxidant network expression abrogates oxidative posttranslational modifications in mice. Am J Physiol Heart Circ Physiol (2011) 0.89
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation (1997) 0.89
Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism. Hypertension (1999) 0.89
Flavonol-cinnamate cycloadducts and diamide derivatives from Aglaia laxiflora. J Nat Prod (2000) 0.88
Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation (2000) 0.88
Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol (2001) 0.88
Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats. Am J Hypertens (1996) 0.88
Molecular analysis of human prorenin prosegment variants in vitro and in vivo. J Biol Chem (1995) 0.88
Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens (1993) 0.88
ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Hypertension (2001) 0.87
Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats. Hypertension (2000) 0.87